IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $462,157 | -49.2% | 101,573 | -21.4% | 0.00% | – |
| Q2 2023 | $909,568 | -3.6% | 129,200 | -16.4% | 0.00% | – |
| Q1 2023 | $943,909 | -65.0% | 154,486 | -63.4% | 0.00% | -100.0% |
| Q4 2022 | $2,694,088 | -82.8% | 421,610 | -74.3% | 0.00% | -66.7% |
| Q3 2022 | $15,706,000 | +6.6% | 1,639,535 | +22.9% | 0.00% | 0.0% |
| Q2 2022 | $14,728,000 | -92.2% | 1,334,062 | -88.2% | 0.00% | -90.6% |
| Q1 2022 | $187,957,000 | +2.7% | 11,288,726 | +17.8% | 0.03% | +10.3% |
| Q4 2021 | $182,959,000 | -16.6% | 9,584,082 | +7.7% | 0.03% | -21.6% |
| Q3 2021 | $219,462,000 | +16.3% | 8,899,530 | +22.7% | 0.04% | +19.4% |
| Q2 2021 | $188,677,000 | -17.8% | 7,251,243 | +0.0% | 0.03% | -22.5% |
| Q1 2021 | $229,460,000 | -11.9% | 7,247,657 | +29.1% | 0.04% | -16.7% |
| Q4 2020 | $260,394,000 | +1122.0% | 5,611,932 | +767.0% | 0.05% | +1100.0% |
| Q3 2020 | $21,309,000 | +19.5% | 647,310 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $17,827,000 | -66.4% | 649,432 | -63.4% | 0.00% | -71.4% |
| Q1 2020 | $53,116,000 | -20.2% | 1,774,372 | -26.2% | 0.01% | 0.0% |
| Q4 2019 | $66,535,000 | +218.3% | 2,403,704 | +109.3% | 0.01% | +180.0% |
| Q3 2019 | $20,905,000 | +120.1% | 1,148,635 | +196.5% | 0.01% | +150.0% |
| Q2 2019 | $9,498,000 | +1074.0% | 387,377 | +512.6% | 0.00% | – |
| Q2 2018 | $809,000 | -33.3% | 63,237 | -11.9% | 0.00% | – |
| Q1 2018 | $1,213,000 | – | 71,785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |